EU Decision Imminent On Comirnaty Booster, Data Expected On Use In 5-11 Year Olds
The European Medicines Agency also expects to reach some conclusions on the use of MAb-based COVID-19 treatments by the end of October.

The European Medicines Agency also expects to reach some conclusions on the use of MAb-based COVID-19 treatments by the end of October.